Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2013 Jan 1;62(1):10–16. doi: 10.1097/QAI.0b013e318271c450

Table II.

Neutralization of HIV by Milk Derived b12 IgA2a

CHO
Purifiedb
Milk Purified Milk Expressed
SF162 (IC90)c 1.03 ± 0.52 0.79 ± 0.29 0.34 ± 0.13d
67970 (IC50)c 8.68 ± 3.05 12.94 ± 5.47 1.52 ± 0.73d
JR-FL (IC50)c 7.27 ± 2.45 27.60 ± 16.17 2.72 ± 1.49d
89.6 (IC90) c 6.75 ± 2.63 8.37 ± 3.10 1.85 ± 1.53d
a

Neutralization was measured using TZM-bl assay

b

b12 IgA2 antibody was purified from CHO cells, milk and tested as expressed in milk.

c

Virus isolate tested with indication of either IC90 or IC50 values were used as determined by linear regression analysis

d

Enhanced neutralization by milk-expressed b12 IgA2 reached statistical significance when compared to purified antibody (CHO or milk) with p<0.05